Modeling mitigation of influenza epidemics by baloxavir by Zhanwei Du, Ciara Nugent, Alison P. Galvani, Robert M. Krug, Lauren Ancel Meyers

Get full text

Structural similarities between SARS-CoV2 3CLpro and other viral proteases suggest potential lead molecules for developing broad spectrum antivirals by Khushboo Bafna, Khushboo Bafna, Christopher L. Cioffi, Robert M. Krug, Gaetano T. Montelione, Gaetano T. Montelione

Get full text

Biochemical and Structural Evidence in Support of a Coherent Model for the Formation of the Double-Helical Influenza A Virus Ribonucleoprotein by Qiaozhen Ye, Tom S. Y. Guu, Douglas A. Mata, Rei-Lin Kuo, Bartram Smith, Robert M. Krug, Yizhi J. Tao

Get full text

Public Health Impact of Paxlovid as Treatment for COVID-19, United States by Yuan Bai, Zhanwei Du, Lin Wang, Eric H.Y. Lau, Isaac Chun-Hai Fung, Petter Holme, Benjamin J. Cowling, Alison P. Galvani, Robert M. Krug, Lauren Ancel Meyers

Get full text

Influenza NS1 directly modulates Hedgehog signaling during infection. by Margery G Smelkinson, Annabel Guichard, John R Teijaro, Meghana Malur, Maria Eugenia Loureiro, Prashant Jain, Sundar Ganesan, Elina I Zúñiga, Robert M Krug, Michael B Oldstone, Ethan Bier

Get full text

Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture by Khushboo Bafna, Kris White, Balasubramanian Harish, Romel Rosales, Theresa A. Ramelot, Thomas B. Acton, Elena Moreno, Thomas Kehrer, Lisa Miorin, Catherine A. Royer, Adolfo García-Sastre, Robert M. Krug, Gaetano T. Montelione

Get full text